Loading...
Please wait, while we are loading the content...
Tratamiento de la hiperglucemia en el paciente con diabetes tipo 2 e hígado graso no alcohólico
| Content Provider | Semantic Scholar |
|---|---|
| Author | Pérez, Araceli Pérez Donaire, Inka Miñambres |
| Copyright Year | 2017 |
| Abstract | The focus of pharmacological treatment of hyperglycemia in patients with type 2 diabetes has changed considerably in recent years. Individualisation is a key element when establishing a therapy, considering both the patient’s characteristics and diabetes as well as the potential benefits and risks of therapy. Patients with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) constitute a subset of metabolically complex patients with a higher risk of developing cardiovascular and microangiopathic complications. Moreover, diabetes is a marker of progression of NAFLD. All these factors pose a challenge to the treatment of these patients and represent a clinical scenario that justifies the use of specific therapeutic options. In the present article, we review the available data on the effects of the different hypoglycaemic drugs on NAFLD and associated metabolic alterations, and the strategy for their selection in patients with type 2 diabetes and NAFLD. © 2017 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved. Tratamiento de la hiperglucemia en el paciente con diabetes tipo 2 e hígado graso no alcohólico 29 |
| Starting Page | 28 |
| Ending Page | 33 |
| Page Count | 6 |
| File Format | PDF HTM / HTML |
| Volume Number | 1 |
| Alternate Webpage(s) | https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=X2530016417615212 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |